Dexmedetomidine for sedation of patients in the intensive care unit during intrahospital transports to diagnostic tests

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002743

Enrollment

Unknown

Registered

2012-11-29

Start date

2013-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically disease

Interventions

Dexmedetomidine Group:Dexmedetomidine

Control Group:saline

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) patients in the ICU; (2) intrahospital transport to diagnostic tests; (3) without the artificial airway; (4) without sedation and RASS score 0-1.

Exclusion criteria

Exclusion criteria: (1) age <18 years; (2) pregnant or lactating women; (3) patients are known to be allergic to the study drugs or other contraindications; (4) patients can not be given drugs according to the study design, such as MRI; (5) alcoholism, long-term use of sedatives and opioid addicts; (6) MAP <55mmHg or left ventricular ejection fraction <30% although the optimalfluid resuscitation and vasoactive drugs therapy. (7) HR <50/min; (8) uncontroled arrhythmias, such as ?or ? atrioventricular block; (9) acute coronary syndrome (such as unstable angina, acute myocardial infarction); (10) serious internal environment disorder: K + = 5.5, pH <7.2; (11) patients who need emergency treatment or rescue; (12) consent of the patients or their family members can not be obtained; (13) patients who were included in the study once or being in other studies which may affect the study.

Countries

China

Contacts

Public ContactKaijiang Yu

drkaijiang@sohu.com+86 13303608899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026